Vandria is a biopharmaceutical company that develops best-in-class small molecule mitophagy inducers to treat age-related and chronic diseases in the fields of Muscle- and CNS diseases with large unmet medical need.

Vandria develops best-in-class mitophagy inducers that rejuvenate cells by restoring mitochondrial health. Mitochondria are double-membrane organelles that play a critical role in generating most of cellular energy. Mitophagy is a key pathway by which portions of damaged mitochondria are eliminated and recycled using the autophagy machinery, and is required to maintain proper mitochondrial function.